Presentation TCT 2018 Percutaneous Deep Vein aRterialization for the Treatment of Late Stage Critical LiMb ISchEmia, The PROMISE Trial: Early Feasibility Interim Results (LimFlow) Presenter: George L Adams, Tony Das, Steve Henao September 21, 2018
Presentation ACC 2018 A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial) Presenter: Mehdi H. Shishehbor March 12, 2018
Presentation TCT 2017 24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Costantino Del Giudice November 01, 2017
Presentation TCT 2017 Critical Limb Ischemia Update, and the STOP-PAD Trial Presenter: Timothy D. Henry, Marc S. Penn, Mehdi H. Shishehbor October 31, 2017
Presentation TCT 2017 Clinical Trials Using RAPID: Some POC Thoughts Presenter: Schuyler Jones, Hiroyoshi Yokoi, Theodore Heise October 30, 2017
Presentation TCT 2017 Should Alleviating ISCHEMIA Be the Goal? Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno October 30, 2017
Presentation TCT 2016 Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial Presenter: Michael D. Dake, Kenneth Rosenfield, Costantino Del Giudice November 01, 2016
Presentation TCT 2016 Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen November 01, 2016
Presentation TCT 2016 Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Jorge Gaspar, Bernard J. Gersh October 30, 2016
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns! Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel October 15, 2015
Presentation TCT 2015 What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont Presenter: J. A. Mustapha, Craig M. Walker, Gary M. Ansel October 11, 2015
Presentation TCT 2015 From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA? Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Sripal Bangalore October 11, 2015
Presentation Meta-analysis of Trials on Mortality After PCI vs OMT in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia Presenter: H. Gada March 24, 2015
Presentation TCT 2014 Ischemia and Clinical Outcomes: The Missing Mechanistic Link Presenter: Bernard De Bruyne, Manesh R. Patel, Allen Jeremias September 14, 2014
Presentation TCT 2014 Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte September 14, 2014
Presentation Cell Therapy 2014 Safety and Feasibility Trial of Adipose Derived Regenerative Cells in Treatment of Chronic Myocardial Ischemia (ATHENA) Presenter: Emerson C. Perin January 22, 2014
Presentation Predicting Outcome in the COURAGE Trial: Coronary Anatomy vs. Ischemia Presenter: G.B. John Mancini January 14, 2014
Presentation TCT 2013 Rationale, Design and Status of the ISCHEMIA Trial Presenter: David Maron October 28, 2013
Presentation TCT 2012 DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee... Presenter: Francesco Liistro October 25, 2012
Presentation Cell Therapy 2012 Adipose-Derived Cells for Chronic Ischemia: The PRECISE Trial Presenter: Emerson C. Perin January 25, 2012